Zappy Zapolin’s Psycheceutical Files Patent, Hopes Ketamine Topical Can Treat PTSD

January 26, 2023 · Benzinga

Lifesciences biotech company Psycheceutical Bioscience 

BWVI, of which Benzinga’s advisory council member Zappy Zapolin is Chief Visionary Officer, patented a topical ketamine formulation to treat PTSD.

The patent includes related methods using drug delivery technology NeuroDirect.

Psycheceutical CEO Chad Harman says NeuroDirect’s topical delivery system could potentially provide “new solutions and treatments for PTSD and other mental health conditions,” considering the disorder is in some cases associated with anxiety, depression and substance use disorder.

The system’s design would topically distribute neuro-active compounds to the back of the neck for immediate and sustained action on brain nerve endings.

The new formulations and treatment methods intend to reduce PTSD-related pain and symptoms with safe dosage control while reducing side effects such as hallucinations, nausea, lethargy and toxicity.

“Psycheceutical is driven to provide new hope for this debilitating disorder by employing cutting-edge technologies for the patients who need it most,” the company’s CMO, Julian Bailes, says. “We look forward to improving current mental health treatments while progressing the capabilities of the psychedelic pharmaceutical category.” (Full Story)

In category:Medical
Next Post

Psychedelics May Be Part of U.S. Medicine Sooner Than You Think

It came as a surprise to many when, on Feb. 3, Australian regulators announced that medicines containing the psychedelic substances MDMA and psilocybin can soon be used there to treat post-traumatic stress disorder (PTSD) and treatment-resistant depression, respectively. That decision makes Australia…
Read
Previous Post

Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin

Core One Labs' Akome Partners To Study Next-Gen Psychedelics A subsidiary of Core One Labs  CLABF has signed a contract with Fundació Bosh I Gimpera to begin second-phase studies evaluating the therapeutic potential of its bio-compounds (both alone and combined with psychedelic substances). The…
Read
Random Post

Denver's Illegal Cannabis Activity Falls, but So Do Legal Sales

Nearly a decade after Colorado ushered in legal adult-use cannabis sales, police in the state’s capital city report a significant drop in illicit product on the streets. According to the report from Denver’s municipal government, the city – which was the first…
Read
Random Post

Bipartisan Federal Proposal Seeks to Update Hemp-Derived CBD Rules

A group of federal lawmakers last week introduced bipartisan, bicameral legislation aimed at updating federal hemp rules to ensure hemp-derived CBD products are regulated by the U.S. Food and Drug Administration (FDA) like other legal products used in dietary supplements, foods, and beverages.  …
Read
Random Post

GOP Candidate Ramaswamy Supports Federal Marijuana Legalization And Allowing Veterans To Use Psychedelics

Republican presidential candidate Vivek Ramaswamy says he supports federally legalizing marijuana and allowing veterans with PTSD to use certain psychedelics—but his campaign is also attacking a recent Fox News article that suggested he supports decriminalizing “certain hard drugs” even though…
Read
Random Post

Cannabis retail sales to surpass $33.5B in 2023, topping chocolate, eggs and craft beer

Chris Morris Thu, April 13, 2023 at 12:08 AM GMT+7·2 min read Jeenah Moon/Bloomberg via Getty Images As more and more states make medical and recreational cannabis legal, the drug’s retail sales numbers are hitting new heights. More from Fortune: 5 side hustles where you…
Read